Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT

Journal of Nuclear Medicine

Volumn 37, Issue 3, 1996, Pages 513-520

  Ichise, Masanori ^a   Ballinger, James R ^b   Golan, Haim ^b   Vines, Douglass ^b   Luong, Angela ^b   Tsai, Scott ^b   Kung, Hank F ^b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

brain SPECT; dopamine D2 receptors; iodine 123 IBF; noninvasive quantification

Indexed keywords

BENZOFURAN DERIVATIVE; DOPAMINE 2 RECEPTOR; IODINE 123;

ARTICLE; BLOOD SAMPLING; BRAIN BLOOD FLOW; BRAIN MAPPING; COMPARTMENT MODEL; DIAGNOSTIC IMAGING; IMAGE ANALYSIS; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RECEPTOR OCCUPANCY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BENZOFURANS; BRAIN; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; MODELS, BIOLOGICAL; PYRROLIDINES; RECEPTORS, DOPAMINE D2; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029864267     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. 123I]IBZM, a potential CNS D-2 dopamine receptor imaging agent. J Nucl Med 1989;30:88-92.
2. Brucke T, Podreka I, Angelberger P, et al. Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatrie disorders. J Cereb Blood Flow Metab 1991;11:220-228.
3. Ichise M, Toyama H, Fornazzari L, Ballinger JR, Kirsh JC. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease J Nucl Med 1993,34:1274-1281.
4. Oertel WH, Schwarz J, Tatsch K, Arnold G, Gasser T, Kirsch CM IBZM-SPECT as predictor for dopamimetic responsiveness of patients with de novo parkinsonian syndrome. Adv Neurol 1993;60.519-524
5. 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease. Nucl Med Commun 1991;12 699-707.
6. 123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism Neurology 1992,42 556-561.
7. 123I. Arch Neurol 1993; 50:509-512.
8. 123I-IBZM single-photon emission computed tomography Arch Neurol 1993,50.513-516.
9. Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NP, Kerwin RW. Clozapine, single photon emission tomography and the D2 dopamine receptor blockade hypothesis of schizophrenia Lancet 1992;340:199-202.
10. Kung MP, Kung HF, Billings J, Yang Y, Murphy RA, Alavi A The characterization of IBF as a new selective dopamine D2 receptor imaging agent. J Nucl Med 1990;31:648-654
11. Kessler RM, Ansari MS, de Paults T, et al. High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides. J Nucl Med 1991;32:1593-1600
12. Al-Tkriti MS, Baldwin RM, Zea-Ponce Y, et al Comparison of three high affinity SPECT radiotracers tor the dopamine D2 receptor. Nucl Med Biol 1994;21:179-188
13. 123I]2′-ISP in nonhuman primates Nucl Med Biol 1994;21:969-976
14. Laruelle M, van Dyck C, Abi-Dargham A, et al Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects. J Nucl Med 1994,35:743-754
15. Farde L, Hall H, Ehrin E, Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 1986;231:258-261.
16. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1990,10:740-747.
17. Lassen NA Neuroreceptor quantitation in vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers. J Cereb Blood Flow Metab 1992;12:709-716.
18. 11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography J Cereb Blood Flow Metab 1989,9 398-409.
19. Phelps ME, Huang SC, Hoffman EJ, Kuhl DE. Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin J Nucl Med 1979;20:328-334
20. 18F]cyclofoxy and positron emission tomography. J Cereb Blood Flou Metab 1993;13:24-42
21. Murphy RA, Kung HF, Kung MP, Billings J. Synthesis and characterization of iodobenzamide analogues, potential D-2 dopamine receptor imaging agents. J Med Chem 1990;33:171-178
22. Billings JJ, Kung MP, Chumpradit S, Mozley D, Alavi A, Kung HF Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor. J Neurochem 1992,58 227-236.
23. Chang L A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978,NS-25.638-643
24. Talairach J, Tournoux P, Rayport M, eds Co-planar stereotaxic atlas of the human brain Three-dimensional proportional system an approach to cerebral imaging New York: Thieme Inc ; 1988:1-122
25. 11C-raclopride in living human brain - a search for extrastriatal central D2-dopamine receptors by PET. Psychopharmacology 1988;94 471-478.
26. 11C]raclopride binding to D2-dopamine receptors studied by PET - a comparison to the equilibrium analysis J Cereb Blood Flow Metab 1989;9 696-708.
27. Levenberg K A method for the solution of certain problems in least squares Q Appl Math 1944,2 164-168
28. Abi-Dargham A, Laruelle M, Seibyl J, et al SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil. kinetic and equilibrium paradigms. J Nucl Med 1994;35.228-238
29. Billings JJ, Guo YZ, Kung MP, Kung HF Localization of IBF as a D2 dopamine receptor imaging agent in nonhuman primates Eur J Nucl Med 1993;20:1146-1153.
30. D with the opiate antagonist cyclofoxy equilibrium studies in the conscious rat J Cereb Blood Flow Metab 1991;2 529-544
31. 123I]IBF for dopamine D2/D3 receptors in humans [Abstract]. J Nucl Med 1994;35:84P.
32. 3H-raclopride. J Neural Transm 1988;73:7-21
33. 125I]epidepride. Brain Res 1993;609 237-243.
34. Van Tol HH, Bunzow JR, Guan HC, et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nantie 1991;350:610-614.
35. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990;347:146-151.
36. 11C-raclopride. Arch Neurol 1993;50:474-480.
37. 11C]raclopride. J Cereb Blood Flow Metab 1993;13:310-314.
38. Seeman P, Bzowej NH, Guan HC, et al. Human brain dopamine receptors in children and aging adults. Synapse 1987;1:399-404